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Abstract  
Objective: To study the association of acne with metabolic syndrome and insulin resistance in young men. Study 
Design: A Cross-sectional study. Place and Duration of Study: Department of  Dermatology Services Hospital, 
Lahore. From January 5, 2016 to January 5, 2018. Methodology: A total of 158 patients were selected for study. 
Age, weight, height, waist, systolic and diastolic blood pressures, serum HDL-C levels, serum triglycerides, 
fasting blood glucose, fasting plasma insulin, and HOMA-IR score were documented in each patient. Student t-
test was applied to compare these variables between cases and controls; and ANOVA test was applied to 
compare among the acne severity groups. Patients having metabolic syndrome and insulin resistance were 
compared by applying chi-square test. The data was analyzed by using SPSS v.23 software, considering p≤0.05 
statistically significant. Results: Mean systolic and diastolic blood pressures, fasting blood glucose and HOMA-
IR score of the cases were significantly high when compared with controls (p-value .015, .002, .022 and .040, 
respectively). The frequency of metabolic syndrome was 26.58% in the cases and 8.86% of the controls 
(p=0.004); and of Insulin resistance was 27.85% in cases, while 11.39% in controls (p=0.008). The differences 
were statistically significant. The difference of systolic and diastolic blood pressures was statistically different in 
four acne severity groups (p-value .024 and .015, respectively), with systolic blood pressure being the lowest and 
diastolic blood pressure being the highest in mild acne group. Conclusion: The observations of our study 
concluded that post-pubertal males with acne are at higher risk of developing metabolic syndrome and insulin 
resistance when compared with the normal population.  
Keywords: Acne, Metabolic syndrome, Insulin Resistance, Blood pressure 
 
Introduction 
Acne is an illness of pilosebaceous units 1. Adolescents are the part of population that are most affected by this 
disorder 2. Size of sebaceous gland, increased production of sebum and keratinocyte proliferation are stimulated 
by the androgens 3, this in turn leads to increased incidence of acne after puberty. Hyperinsulinemia occurs due 
to development of physiologic resistance to insulin, during puberty 4, in turn increasing the synthesis of 
androgens. Acne formation is augmented by both these events. Hyperinsulinemia results in raised levels of 
insulin like growth factor1 (IGF-1); and thus decreasing the levels of insulin-like growth factor-binding protein 
level in the serum. The consequences of increased insulin like growth factor1 (IGF-1) levels are raised serum 
dihydrotestosterone and dehydroepiandrosterone sulfate, deceased production of sex hormone-binding proteins 
by the liver, increased sebocyte proliferation and increased rate of facial sebum excretion. Levels of transforming 
growth factor and epidermal growth factor are also increased in hyperinsulinemia, in turn elevation of non-
esterified fatty acids component of plasma, thereby triggering inflammation and acne. A critical role is played by 
insulin resistance in many metabolic aberrations that are constituents of the metabolic syndrome. 
Acne is associated with polycystic ovarian syndrome (PCOS) 5, 6, 7, in women, is a disorder linked with 
hyperinsulinemia, insulin resistance and hyperandrogenism 6; and this supports the concept of role of insulin in 
the progression of acne. The treatment options which decrease the insulin secretion and/or improve the 
sensitivity of insulin, for example metformin or acarbose 8, have also shown to decrease serum androgens level, 
gonadotropins and to improve hirsutism, acne, fertility, menstrual cycle and ovulation. Women, who don’t have 
explicit polycystic ovarian syndrome but have post-pubertal acne, often sustain raised serum concentration of 
insulin like growth factor1 (IGF-1); and are somewhat insulin resistant as well. In adult women, the acne lesion 
numbers have been analogous to the insulin like growth factor1 (IGF-1) levels 9 and significantly higher levels 
insulin like growth factor1 (IGF-1) were demonstrated in such women as compared to the controls.  
Acne occurrence matches more with the fluctuations in the insulin and insulin like growth factor1 (IGF-1) 
levels than it matches with the change of plasma androgen levels. This is for the reason that the insulin-like 
growth factor-1 (IGF-1) and insulin levels become highest during adolescence 10 and gradually fall during the 
third decade of life. Insulin resistance might continue, in post-pubertal patients with acne. Hence, insulin 
resistance might have part in the progress of post-pubertal acne. 
The relationship of acne with metabolic syndrome and insulin resistance has been studied poorly, in the past. 
Current study is intended to study the frequency of metabolic syndromes and insulin resistance in the young 
male individuals who present with acne. We aim to study the effects of these events over the metabolic profile of 
the patients.  
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Material n methodology 
This is a cross-sectional study and the relevant data was collected in Department of  Dermatology Services 
Hospital, Lahore, over a time period from January 5, 2016 to January 5, 2018. The consent was taken from the 
hospital ethical committee. Sample size was calculated using the study by Nagpal M. et al. 11 as reference. Non-
probability consecutive sampling technique was used to select seventy nine cases i.e. male patients diagnosed of 
acne and an equal number of age-matched controls. 
Informed consent was taken from all the subjects enrolled in the study on written forms. Clinical 
examination was performed after taking comprehensive history. Weight, height, waist circumference, blood 
pressure were measured and defining the severity of acne according to the Global Acne Grading System was 
completed. The measuring tape was placed tightly round the belly at the level of iliac crests and waist 
circumference was noted. Mercury sphygmomanometer was used to measure blood pressure level, in sitting 
position. Modified National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII) was 
applied to diagnose metabolic syndrome; which includes minimum three of the subsequent criteria: central 
obesity (waist circumference ≥ 102cm; modified for Asian men > 90cm) ; dyslipidemia (serum triglyceride level 
≥ 150mg/dl) or medical treatment for elevated levels; dyslipidemia (serum HDL-C levels < 40mg/dl) or medical 
treatment for altered levels; blood pressure of 135/85 mmHg or medical treatment for hypertension; and fasting 
blood glucose levels of ≥ 100mg/dl or medical treatment for diabetes mellitus. An electrochemiluminescence 
immunoassay was used to assess the fasting plasma insulin levels. Homeostasis Model Assessment-Insulin 
Resistance (HOMA-IR) score was calculated by the application of subsequent principle: Fasting Plasma Insulin 
(µIU/ml) × Fasting Blood Glucose (µg/dl)/405. Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) 
score of more than 2.5 was considered as insulin resistance. All the subjects who had history of hepatic disorders, 
malignancies, thyroid dysfunctions, acromegaly, Cushing syndrome and smoking; and those who were recently 
treated with isotretinoin, were excluded from our study, owing to the ability of these factors to alter insulin and 
insulin like growth factor levels and status of insulin resistance. 
Age, weight, height, waist, systolic and diastolic blood pressures, serum high density lipoprotein-cholesterol, 
serum triglycerides level, fasting blood glucose, fasting plasma insulin, and Homeostasis Model Assessment-
Insulin Resistance (HOMA-IR) score were documented in each patient. Student t-test was applied to compare 
these variables between cases and controls; and ANOVA test was applied to compare these parameters among 
the cases according to the severity of the acne. Patients having Insulin resistance as per HOMA-IR score >2.5 
and metabolic syndrome as per National Cholesterol Education Program Adult Treatment Panel III (NCEP-
ATPIII) were counted in both groups and the data was analyzed by applying chi-square test. All the data was 
collected by the researcher himself, on a preformed Performa. SPSS v.23 software was used to analyze the data. 
P ≤0.05 was taken as statistically significant.  
 
Results 
A total of 158 male patients were involved in the study. Seventy nine patients with acne were selected and equal 
number of age matched controls were selected. The mean age, weight, height and waist circumference of the 
cases were 22.91±2.93years, 65.34±8.17Kg, 160.87±4.28cm and 87.44±6.46cm; and of controls were 
22.54±3.05years, 62.00±6.91Kg, 160.87±4.71cm, and 85.39±5.76cm, respectively (p-value 0.442, 0.006, 0.778 
and 0.037, respectively). The mean systolic and diastolic blood pressures of the cases were 129.65±9.13mmHg 
and 78.01±7.27mmHg, and were significantly high when compared with controls i.e. 119.57±8.29mmHg and 
71.49±6.39mmHg, respectively (p<0.001 for both). The mean fasting blood glucose level and HOMA-IR score 
of the cases were 90.33±5.44mg/dl and 2.32±1.14, and were significantly higher than they were of controls i.e. 
80.34±7.03mg/dl and 1.74±0.93, respectively (p <0.001 and 0.001, respectively). The mean serum triglyceride 
level of the cases (94.00±40.39mg/dl) was significantly lower (p=0.019) than that of controls 
(108.14±34.08mg/dl). Both the groups were comparable in terms of serum HDL cholesterol levels and fasting 
plasma insulin concentrations (47.07±8.52mg/dl and 9.56±4.83 µIU/ml in the cases; and 44.86±8.17mg/dl and 
8.33±3.07 µIU/ml in controls, p-value 0.097 and 0.059, respectively. The percentage of metabolic syndrome was 
26.58% in the cases and 8.86% of the controls and the difference was statistically significant (p=0.004). Insulin 
resistance, defined as HOMA-IR score of more than 2.5, was noticed in 27.85% of the cases and 11.39% of the 
controls and the difference was also statistically significant (p=0.008). (Table-I) 
The differences of mean age and weight were significantly different in four different groups of acne 
severity, in mild acne being the lowest and in very severe acne being the highest (p-value .017 and <.001, 
respectively). The mean height and waist circumference was not statistically different (p-value .308 and .893, 
respectively). The difference of systolic and diastolic blood pressure was statistically different in four acne 
severity groups (p-value .024 and .015, respectively), with systolic blood pressure being the lowest and diastolic 
blood pressure being the highest in mild acne group. There was no statistically significant difference in serum 
HDL-Cholesterol level, serum triglycerides level, fasting blood glucose levels, fasting plasma insulin levels and 
HOMA-IR score among these four groups (p-value .952, .970, .571, .718 and .594, respectively). The percentage 
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of metabolic syndrome and insulin resistance was 20% and 25% in mild acne; 25% and 30% in moderate acne; 
30% and 20% in severe acne; and 31.58% and 36.84% in very severe acne groups, respectively. The differences 
were not statistically significant (p-value .842 and .681 for metabolic syndrome and Insulin resistance, 
respectively). (Table-II) 
Table-I 
Study Factors in Two Study Groups 
Factor Cases Controls p-value 
Age (years) 22.91±2.93 22.54±3.05 0.442 
Weight (Kg) 65.34±8.17 62.00±6.91 0.006 
Height (cm) 160.87±4.28 160.87±4.71 0.778 
Waist Circumference (cm) 87.44±6.46 85.39±5.76 0.037 
SBP (mmHg) 129.65±9.13 119.57±8.29 <0.001 
DBP (mmHg) 78.01±7.27 71.49±6.39 <0.001 
Serum HDL-C (mg/dl) 47.07±8.52 44.86±8.17 0.097 
Serum Triglycerides (mg/dl) 94.00±40.39 108.14±34.08 0.019 
Fasting Blood Glucose (mg/dl) 90.33±5.44 80.34±7.03 <0.001 
Fasting Plasma Insulin (µIU/ml) 9.56±4.83 8.33±3.07 0.059 
HOMA-IR 2.32±1.14 1.74±0.93 0.001 
Metabolic Syndrome (%) * 26.58 8.86 0.004 
Insulin Resistance (%) ** 27.85 11.39 0.008 
Data are mentioned as Mean ± S.D lest specified otherwise; SBP=systolic blood pressure; DBP=diastolic blood 
pressure; HOMA-IR=Homeostasis Model Assessment-Insulin Resistance; HDL-C=high density lipoprotein 
cholesterol; *Metabolic syndromes assessed by National Cholesterol Education Program Adult Treatment Panel 
III (NCEP-ATPIII); **Insulin resistance was outlined as HOMA-IR score >2.5. 
Table-II 
Study Factors in Four Acne Severity Groups 
Factor Mild Acne Moderate 
Acne 
Severe 
Acne 
Very Severe 
Acne 
p-
value 
Age (years) 22.50±2.42 22.25±2.71 22.25±2.51 24.73±3.46 .017 
Weight (Kg) 59.50±5.92 63.60±6.48 68.35±8.68 70.16±7.26 <.001 
Height (cm) 159.75±4.49 161.00±3.91 162.25±4.49 160.47±4.11 .308 
Waist Circumference (cm) 88.15±6.48 87.60±5.31 87.45±6.65 86.52±7.66 .893 
SBP (mmHg) 125.25±9.10 128.30±8.81 132.30±6.15 132.89±10.45 .024 
DBP (mmHg) 82.40±8.57 77.20±6.39 76.50±6.80 75.84±5.49 .015 
Serum HDL-C (mg/dl) 47.40±7.97 46.25±9.80 47.75±8.33 46.89±8.44 .952 
Serum Triglycerides (mg/dl) 95.65±42.08 92.65±41.03 91.05±38.39 96.79±42.92 .970 
Fasting Blood Glucose (mg/dl) 89.55±6.00 91.80±4.68 89.90±5.39 90.05±5.72 .571 
Fasting Plasma Insulin 
(µIU/ml) 
9.18±4.07 9.29±4.66 10.65±5.71 9.09±4.97 .718 
HOMA-IR 2.10±1.08 2.37±1.22 2.23±1.03 2.58±1.24 .594 
Metabolic Syndrome (%) * 20 25 30 31.58 .842 
Insulin Resistance (%) ** 25 30 20 36.84 .681 
Data are mentioned as Mean ± S.D lest specified otherwise; SBP=systolic blood pressure; DBP=diastolic blood 
pressure; HOMA-IR=Homeostasis Model Assessment-Insulin Resistance; HDL-C=high density lipoprotein 
cholesterol; *Metabolic syndromes assessed by National Cholesterol Education Program Adult Treatment Panel 
III (NCEP-ATPIII); **Insulin resistance was outlined as HOMA-IR score >2.5. 
 
Discussion 
In current study, we see that the young male patients who develop acne are more predisposed to have high 
systolic blood pressure along with more chances of developing pre-diabetic condition. The level of serum insulin 
in fasting patients was also observed to be raised as compared with the normal population. When comparing the 
different acne severity groups, the weight and systolic blood pressure were seen to increase as the severity of 
acne progressed. Over all, the number of patients to develop metabolic syndrome and insulin resistance was also 
significantly more in the acne group as compared with the control group. 
The results of the study by Nagpal M. et al. 11 were similar to those of current study. They showed that the 
patients presenting with acne had higher systolic as well as diastolic blood pressures, but, in current study we 
observed that the diastolic blood pressure was seen to be lower in the acne patients as compares to that of 
controls. They concluded that the adolescent patients with acne had greater risk of developing hypertension, 
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diabetes mellitus and other metabolic derangements, in future. Cerman et al. 12 found out that higher glycemic 
index was associated with acne vulgaris. The studies by Emiroğlu N et al. 8 and Del Prete M. et al. 14 suggested 
that insulin resistance had some role to play in the pathological sequel of the acne. Kartal D. et al.13 directed a 
study on women and observed that the use of metformin, a euglycemic drug for diabetes mellitus, by the patients 
presenting with acne resulted in improvement of their acne symptoms. This is clearly suggestive of an 
association of insulin resistance and acne.  
Kumari R. et al. 15 witnessed in their study that the use of hyperglycemic diets which led to the induction of 
insulin and IGF-1-mediated P13 kinase ∕ Akt activation caused the sebaceous lipogenesis and increase of 
sebocyte and keratinocyte which could cause acne. Ben‐Amitai D. 16 suggested that the deficiency of insulin-like 
growth factor 1 had protective role against acne. Alan S. 17 revealed that the increased circulating levels of 
androgens and high body mass index (BMI) increased the occurrence as well as severity of acne in the female 
patients. 
Sabat R. et al. 18 presented that there was high occurrence of metabolic syndromes in the patients presenting 
with acne. According to Saleh BO. 19, the factors which could raise levels of androgens, for example increased 
serum level of insulin like growth factor 1 and growth hormone, also increased the incidence of acne. Due to 
hyperandrogenism, these patients can develop hyperlipidemias. 
 
Conclusion 
The observations of our study concluded that post-pubertal males with acne are at higher risk of developing 
insulin resistance and metabolic syndromes as compared with normal population. Weight and systolic blood 
pressure level also tend to be higher with the increasing severity of acne. 
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